Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences (EW) shares rose 1.43% to $92.28 on Wednesday, marking a second consecutive day of gains. However, the stock underperformed relative to competitors Abbott, Medtronic, and Stryker, which posted higher percentage increases. Trading volume was below the 50-day average. The stock remains 4.16% short of its 52-week high reached in July.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) rallied 1.43% to $92.28 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.
This was the stock's second consecutive day of gains.
Edwards Lifesciences Corp. closed 4.16% short of its 52-week high of $96.29, which the company reached on July 7th.
The stock underperformed when compared to some of its competitors Wednesday, as Abbott Laboratories (ABT) rose 1.55% to $114.43, Medtronic PLC (MDT) rose 2.22% to $94.13, and Stryker Corp. (SYK) rose 2.60% to $339.98.
Trading volume (3.4 M) remained 1.2 million below its 50-day average volume of 4.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-19-26 1649ET